NCT07741240 — Major Depressive Disorder (MDD) trial site landscape

Public-registry site landscape for NCT07741240, a Major Depressive Disorder (MDD) study sponsored by Chengdu Kanghong Pharmaceutical Group Co., Ltd.. All data below is from public sources; Eichor is not affiliated with the sponsor.

Trial	NCT07741240 (registry record)
Sponsor	Chengdu Kanghong Pharmaceutical Group Co., Ltd.
Condition(s)	Major Depressive Disorder (MDD)
Phase	PHASE3
Listed sites	0

Free site-risk snapshot for this trial

Eichor generates a preliminary site-risk snapshot for NCT07741240 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →

Planning or rescuing a trial? Eichor generates evidence-linked site-risk reports from public data in minutes. Get a free preliminary snapshot →